Innovation Pharmaceuticals Inc (IPIX): Formulation (Brilacidin reformulation an...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: oddone33320 post# 72167

Wednesday, 10/01/2014 9:45:49 PM

Wednesday, October 01, 2014 9:45:49 PM

Formulation (Brilacidin reformulation and CMC)and the stability test were required for the INDA submission. Done and done.

“It is difficult to get a man to understand something, when his salary depends on his not understanding it.”
-- Upton Sinclair

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Only $200 per official company press release!